Dapa Met XR 10+500mg Tablet
₨ 633
About this product
Overview
DAPA MET XR 10+500MG TABLET is a combination medication containing two active ingredients: DAPAGLIFLOZIN + METFORMIN. Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and metformin is a biguanide. Together, they work to manage blood sugar levels in individuals with type 2 diabetes.
Uses
- Type 2 Diabetes Mellitus:
- DAPA MET XR 10+500MG TABLET is indicated for the treatment of type 2 diabetes mellitus in adults. It is typically prescribed when blood sugar levels are not adequately controlled by diet and exercise alone.
Components and Mechanism of Action
- Dapagliflozin:
- Dapagliflozin works by inhibiting the reabsorption of glucose in the kidneys, leading to increased urinary excretion of glucose and, consequently, lowering blood sugar levels.
- Metformin:
- Metformin improves the body’s response to insulin, reduces the production of glucose by the liver, and enhances the uptake of glucose by tissues, contributing to better blood sugar control.
Side Effects
Common side effects of DAPA MET XR 10+500MG TABLET may include:
- Genital yeast infections (for dapagliflozin)
- Gastrointestinal disturbances (e.g., nausea, diarrhea) for metformin
- Urinary tract infections
Serious side effects may include:
- Lactic acidosis (for metformin)
- Hypotension (low blood pressure)
- Ketoacidosis (for dapagliflozin)
When Not to Use
- Type 1 Diabetes:
- DAPA MET XR is not intended for the treatment of type 1 diabetes.
- Hypersensitivity:
- Individuals with a known hypersensitivity to dapagliflozin, metformin, or any components of the formulation should avoid using this medication.
Precautions and Warnings
- Renal Impairment:
- DAPA MET XR should be used with caution in individuals with renal impairment, as both dapagliflozin and metformin are excreted by the kidneys.
- Lactic Acidosis:
- Metformin may increase the risk of lactic acidosis, particularly in patients with conditions such as renal impairment or congestive heart failure.
- Dehydration:
- Dapagliflozin may lead to dehydration, especially in elderly patients or those with low blood volume.
Dosage and Administration
- The dosage of DAPA MET XR should be individualized based on the patient’s condition and response to treatment. It is typically taken orally, with or without food.
Patients should follow their healthcare provider’s instructions, monitor for any unusual symptoms, and report side effects promptly. This information is not exhaustive, and healthcare providers should refer to the prescribing information for a comprehensive understanding of the medication.
This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.
Substitutes for Dapa Met XR 10+500mg Tablet
These medicines contain the same salt as Dapa Met XR 10+500mg Tablet (Dapagliflozin + Metformin 500mg), so they are common substitutes. Compare their prices, and change brands only after checking with your doctor or pharmacist.
| Medicine | Manufacturer | Pack | Price |
|---|---|---|---|
| Xiga Met XR 5 500mg Tablet | CCL Pharmaceuticals | 14 tablets | Rs 371 |
Other strengths of Dapagliflozin + Metformin
| Medicine | Manufacturer | Strength | Price |
|---|---|---|---|
| Daglozin M 5/1000mg Tablet | Genix Pharma | 5/1000mg | Rs 252 |
| Daglozin M 5/850mg Tablet | Genix Pharma | 5/850mg | Rs 280 |
| Quisha Met 5/850mg Tablet | Helix Pharma | 5/850mg | Rs 296 |
| Quisha Met 5/1000mg Tablet | Helix Pharma | 5/1000mg | Rs 313 |
Customer reviews
You must be logged in to post a review.
Reviews
Clear filtersThere are no reviews yet.